| Bundesministerium für Bildung und Forschung |  |
| CECAD |  |
| CMMC |  |
| Control-T |  |
| DFG |  |
| Deutsche Krebshilfe |  |
| ERA PER MED |  |
| Fritz Thyssen Stiftung |  |
| Käthe-Hack-Stiftung | |
| Köln Fortune |  |
| Hochhaus-Stiftung | |
| Horizon 2020 |  |
| Jose Carreras Stiftung |  |
| Mundipharma |  |
| Nachlass Nolting | |
| Roche |  |
| UK Köln |  |
New perspective on future targeted therapy approaches published.
Our work on T-PLL cells resembling the phenotype of activated memory-type effector T-cells has been accepted in Blood
New letter evaluating the effects of EDO-S101/tinostamustine published in Leukemia.
New review on current and future strategies in treating T-PLL published in Current Hematologic Malignancy Reports
